ArticleFrontiers in pharmacology2022

Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer.

Chenyang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.